Clinical, patient experience and cost impacts of performing active surveillance on known methicillin-resistant Staphylococcus aureus positive patients admitted to medical-surgical units

American Journal of Infection Control

Volumn 42, Issue 10, 2014, Pages 1039-1043

  Goldsack, Jennifer C ^a   Deritter, Christine ^a   Power, Michelle ^a   Spencer, Amy ^a   Taylor, Cynthia L ^a   Kim, Sofia F ^a   Kirk, Ryan ^a   Drees, Marci ^a  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

Author keywords

Cost; Isolation; Methicillin resistant Staphylococcus aureus; Patient experience; Surveillance

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; EMOTIONAL STRESS; FEMALE; HEALTH CARE COST; HOSPITAL; HOSPITAL POLICY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; RETROSPECTIVE STUDY; SCREENING; AGED; COST; CROSS INFECTION; ECONOMICS; EPIDEMIOLOGICAL MONITORING; HETEROZYGOTE; HOSPITAL DEPARTMENT; INFECTION CONTROL; ISOLATION AND PURIFICATION; MASS SCREENING; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; STAPHYLOCOCCAL INFECTIONS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARRIER STATE; COSTS AND COST ANALYSIS; CROSS INFECTION; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; INFECTION CONTROL; MALE; MASS SCREENING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; SURGERY DEPARTMENT, HOSPITAL;

EID: 84908175973     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2014.07.011     Document Type: Article

References (48)

1. W.R. Jarvis, J. Schlosser, R.Y. Chinn, S. Tweeten, and M. Jackson National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006 Am J Infect Control 35 2007 631 637
2. National Nosocomial Infections Surveillance System National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004 Am J Infect Control 32 2004 470 485
3. K. LeDell, C.A. Muto, W.R. Jarvis, and B.M. Farr SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus Infect Control Hosp Epidemiol 24 2003 639 641
4. J.D. Siegel, E. Rhinehart, M. Jackson, L. Chiarello Health Care Infection Control Practices Advisory Committee 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings Am J Infect Control 35 10 Suppl 2 2007 S65 S164
5. Control Practices Advisory Committee, 2007 guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Available from: http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf. Accessed February 19, 2014.
6. I.M. Gould Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control Int J Antimicrob Agents 28 2006 379 384
7. M.M. Van Rijen, and J.A. Kluytmans Costs and benefits of the MRSA Search and Destroy policy in a Dutch hospital Eur J Clin Microbiol Infect Dis 28 2009 1245 1252
8. R. Diller, A.K. Sonntag, A. Mellmann, K. Grevener, N. Senninger, and F. Kipp Evidence for cost reduction based on pre-admission MRSA screening in general surgery Int J Hyg Environ Health 211 2008 205 212
9. T.B. Karchmer, L.J. Durbin, B.M. Simonton, and B.M. Farr Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus J Hosp Infect 51 2002 126 132
10. C.E. Herr, T.H. Heckrodt, F.A. Hofmann, R. Schnettler, and T.F. Eikmann Additional costs for preventing the spread of methicillin-resistant Staphylococcus aureus and a strategy for reducing these costs on a surgical ward Infect Control Hosp Epidemiol 24 2003 673 678
11. S.A. McGarry, J.J. Engemann, K. Schmader, D.J. Sexton, and K.S. Kaye Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost Infect Control Hosp Epidemiol 25 2004 461 467
12. E.N. Perencevich, D.N. Fisman, M. Lipsitch, A.D. Harris, J.G. Morris, and D.L. Smith Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units Clin Infect Dis 38 2004 1108 1115
13. J.C. Lucet, S. Chevret, I. Durand-Zaleski, C. Chastang, B. Régnier Multicenter Study Group Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study Arch Int Med 163 2003 181 188
14. I. Björholt, and E. Haglind Cost-savings achieved by eradication of epidemic methicillin-resistant Staphylococcus aureus (EMRSA)-16 from a large teaching hospital Eur J Clin Microbiol Infect Dis 23 2004 688 695
15. M. Vriens, H. Blok, A. Fluit, A. Troelstra, C. Van Der Werken, and J. Verhoef Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10 year survey Eur J Clin Microbiol Infect Dis 21 2002 782 786
16. R.T. Lally, E. Lanz, and C.G. Schrock Rapid control of an outbreak of Staphylococcusaureus on a neonatal intensive care department using standard infection control practices and nasal mupirocin Am J Infect Control 32 2004 44 47
17. J. Khoury, M. Jones, A. Grim, W.M. Dunne Jr., and V. Fraser Eradication of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit by active surveillance and aggressive infection control measures Infect Control Hosp Epidemiol 26 2005 616 621
18. A. Muller, D. Talon, A. Potier, E. Belle, G. Cappelier, and X. Bertrand Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units Crit Care 9 2005 257 258
19. A. Pan, G. Carnevale, P. Catenazzi, P. Colombini, L. Crema, and L. Dolcetti Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA 'search and isolate' strategy in a hospital in Italy with hyperendemic MRSA Infect Control Hosp Epidemiol 26 2005 127 133
20. A. Murthy, G. De Angelis, D. Pittet, J. Schrenzel, I. Uckay, and S. Harbarth Cost-effectiveness of universal MRSA screening on admission to surgery Clin Microbiol Infect 16 2010 1747 1753
21. D.J. Diekema, and M.B. Edmond Look before you leap: active surveillance for multidrug-resistant organisms Clin Infect Dis 44 2007 1101 1107
22. A. Tübbicke, C. Hübner, N.O. Hübner, C. Wegner, A. Kramer, and S. Fleßa Cost comparison of MRSA screening and management-a decision tree analysis BMC Health Serv Res 12 2012 438
23. M. Clancy, A. Graepler, M. Wilson, I. Douglas, J. Johnson, and C.S. Price Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital Infect Control Hosp Epidemiol 27 2006 1009 1017
24. C. Fuller, J. Robotham, J. Savage, S. Hopkins, S.R. Deeny, and S. Stone The National One Week Prevalence Audit of Universal Meticillin-Resistant Staphylococcus aureus (MRSA) Admission Screening 2012 PLoS ONE 8 2013 e74219
25. A. Robicsek, J.L. Beaumont, and L.R. Peterson Duration of colonization with methicillin-resistant Staphylococcus aureus Clin Infect Dis 48 2009 910 913
26. C.A. Muto, J.A. Jernigan, B.E. Ostrowsky, H.M. Richet, W.R. Jarvis, and J.M. Boyce SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus Infect Control Hosp Epidemiol 24 2003 362 386
27. J.A. Jernigan, M.G. Titus, D.H. Gröschel, S.I. Getchell-White, and B.M. Farr Effectiveness of contact isolation during a hospital outbreak of methicillin resistant Staphylococcus aureus Am J Epidemiol 143 1996 496 504
28. B.S. Cooper, S.P. Stone, C.C. Kibbler, B.D. Cookson, J.A. Roberts, and G.F. Medley Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature BMJ 329 2004 533
29. G.J. Duckworth, J.L.E. Lothian, and J.D. Williams Methicillin-resistant Staphylococcus aureus: report of an outbreak in a London teaching hospital J Hosp Infect 11 1988 1 15
30. S. Harbarth, Y. Martin, P. Rohner, N. Henry, R. Auckenthaler, and D. Pittet Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus J Hosp Infect 46 2000 43 49
31. H.L. Evans, M.M. Shaffer, M.G. Hughes, R.L. Smith, T.W. Chong, and D.P. Raymond Contact isolation in surgical patients: a barrier to care? Surgery 134 2003 180 188
32. H.E. Knowles The experience of infectious patients in isolation Nurs Times 89 1992 53 56
33. K.B. Kirkland, and J.M. Weinstein Adverse effects of contact isolation Lancet 354 1999 1177 1178
34. S. Saint, L.A. Higgins, B.K. Nallamothu, and C. Chenoweth Do physicians examine patients in contact isolation less frequently? A brief report Am J Infect Control 31 2003 354 356
35. H.T. Stelfox, D.W. Bates, and D.A. Redelmeier Safety of patients isolated for infection control JAMA 290 2003 1899 1905
36. M. Edmond, L. Lyckholm, and D. Diekema Ethical implications of active surveillance cultures and contact precautions for controlling multidrug resistant organisms in the hospital setting Public Health Ethics 1 2008 235 245
37. Health Protection Agency. Investigation of specimens for screening for MRSA. UK standards for microbiology investigations. Available from: http://www.hpa.org.uk/SMI/pdf. Accessed March 4, 2014.
38. M.H. Wernitz, S. Keck, S. Swidsinski, S. Schulz, and S.K. Veit Cost analysis of a hospital wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment Clin Microbiol Infect 11 2005 466 471
39. G. Papia, M. Louie, A. Tralla, C. Johnson, V. Collins, and A.E. Simor Screening high-risk patients for methicillin resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 20 1999 473 477
40. C. Chaix, I. Durand-Zaleski, C. Alberti, and C. Brun-Buisson Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit JAMA 282 1999 1745 1751
41. A.D. Harris, L. Pineles, B. Belton, J.K. Johnson, M. Shardell, and M. Loeb Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial JAMA 310 2013 1571 1580
42. J. Gammon The psychological consequences of source isolation: a review of the literature J Clin Nurs 8 1999 13 21
43. M.W. Wassenberg, D. Severs, and M.J. Bonten Psychological impact of short-term isolation measures in hospitalised patients J Hosp Infect 75 2010 124 127
44. D.J. Morgan, D.J. Diekema, K. Sepkowitz, and E.N. Perencevich Adverse outcomes associated with contact precautions: a review of the literature Am J Infect Control 37 2009 85 93
45. B.C. Hanusch, D.B. O'Connor, P. Ions, A. Scott, and P.J. Gregg Effects of psychological distress and perceptions of illness on recovery from total knee replacement Bone Joint J 96-B 2014 210 216
46. K.J. Petrie, J. Weinman, N. Sharpe, and J. Buckley Role of patients' view of their illness in predicting return to work and functioning after myocardial infarction: longitudinal study BMJ 312 1996 1191 1194
47. S.S. Huang, E. Septimus, K. Kleinman, J. Moody, J. Hickok, and T.R. Avery Targeted versus universal decolonization to prevent ICU infection New Engl J Med 368 2013 2255 2265
48. J.W. Snyder, G.K. Munier, and C.L. Johnson Comparison of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR assay to culture by use of BBL CHROMagar MRSA for detection of MRSA in nasal surveillance cultures from intensive care unit patients J Clin Microbiol 48 2010 1305 1309